It doesn't have the highest yield, but it has enviable dividend coverage and a long history of surviving in a competitive industry.

Novo Nordisk gained a head start in the GLP-1 race but then fell behind; Pfizer is working hard to catch up to the new leader ...

Axsome stock jumped Wednesday after the biotech firm said its Alzheimer's disease agitation drug will get a priority review.

Lupin has signed an exclusive agreement with China-based Gan & Lee Pharmaceuticals to bring Bofanglutide, a new long-acting GLP-1 injection, to India. The deal gives Lupin sole rights to supply and ...

As an aside, see 3 Risks That Can Make UnitedHealth Stock Unattractive. Additionally, see: MSFT Stock A Winner In 2026? JNJ ...

Wall Street enjoyed a guilt-free feast in 2024 as shares of Novo NordiskNVO, Eli LillyLLY and other makers of weight-loss drugs skyrocketed. But a shift in investor appetites then sent key players' ...

Shares of Praxis Precision Medicines (NASDAQ: PRAX) leaped on Monday after the clinical-stage biopharmaceutical company ...

Veeva Systems markets a suite of software services geared toward the biopharmaceutical industry. A wholly owned customer relationship management service is gaining steam for Veeva Systems. With access ...

We have seen 25 institutional investors add shares of $DRUG stock to their portfolio, and 3 decrease their positions in their most recent quarter.

HC Wainwright initiated coverage on Aardvark Therapeutics, Inc. (NASDAQ:AARD) on Monday with a Buy rating and a price forecast of $40. In February, Aardvark Therapeutics, Inc. (NASDAQ:AARD) priced an ...